Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | USP2 | O75604 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.50 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 5/20 | 0.48 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.47 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL592903 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL2839053 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL8463541 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL2841007 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL2836294 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL585734 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL2838417 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL816892 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL2837462 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL28416989 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3453748-B1 | ESTOLIDE BASE OILS AND OLIGOMERIC COMPOUNDS THAT INCLUDE CROSS METATHESIS | BIOSYNTHETIC TECHNOLOGIES LLC (US) | 2021-11-03 | — | — | EP | disclosed |
| EP-3453748-A1 | ESTOLIDE BASE OILS AND OLIGOMERIC COMPOUNDS THAT INCLUDE CROSS METATHESIS | Biosynthetic Technologies, LLC (US) | 2019-03-13 | — | — | EP | disclosed |
| EP-2794824-B1 | PROCESSES FOR PREPARING ESTOLIDE BASE OILS AND OLIGOMERIC COMPOUNDS THAT INCLUDE CROSS METATHESIS | BIOSYNTHETIC TECHNOLOGIES LLC (US) | 2018-10-31 | — | — | EP | disclosed |
| US-10011556-B2 | Processes for preparing estolide base oils and oligomeric compounds that include cross metathesis | BIOSYNTHETIC TECHNOLOGIES, LLC (US) | 2018-07-03 | — | — | US | disclosed |
| US-20170057905-A1 | PROCESSES FOR PREPARING ESTOLIDE BASE OILS AND OLIGOMERIC COMPOUNDS THAT INCLUDE CROSS METATHESIS | BIOSYN HOLDINGS, LLC | 2017-03-02 | — | — | US | disclosed |
| US-20160244397-A1 | PROCESSES FOR PREPARING ESTOLIDE BASE OILS AND BIOBASED COMPOUNDS THAT INCLUDE ETHYLENEOLYSIS | BIOSYN HOLDINGS, LLC | 2016-08-25 | — | — | US | disclosed |
| WO-2016134138-A1 | PROCESSES FOR PREPARING ESTOLIDE BASE OILS AND BIOBASED COMPOUNDS THAT INCLUDE ETHYLENEOLYSIS | BIOSYNTHETIC TECHNOLOGIES, LLC (US) | 2016-08-25 | — | — | WO | disclosed |
| US-9403752-B2 | Processes for preparing estolide base oils and oligomeric compounds that include cross metathesis | BIOSYNTHETIC TECHNOLOGIES, LLC (US) | 2016-08-02 | — | — | US | disclosed |
| US-20160137946-A1 | PROCESSES FOR PREPARING ESTOLIDE BASE OILS AND OLIGOMERIC COMPOUNDS THAT INCLUDE CROSS METATHESIS | BIOSYN HOLDINGS, LLC | 2016-05-19 | — | — | US | disclosed |
| US-20160102037-A1 | Methods of Making Functionalized Internal Olefins and Uses Thereof | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2016-04-14 | — | — | US | disclosed |
| US-20140012023-A1 | PROCESSES FOR PREPARING ESTOLIDE BASE OILS AND OLIGOMERIC COMPOUNDS THAT INCLUDE CROSS METATHESIS | BIOSYNTHETIC TECHNOLOGIES, LLC (US) | 2014-01-09 | — | — | US | disclosed |
| US-8580985-B2 | Processes for preparing estolide base oils and oligomeric compounds that include cross metathesis | BIOSYNTHETIC TECHNOLOGIES, LLC (US) | 2013-11-12 | — | — | US | disclosed |
| US-8569560-B2 | Synthesis of terminal alkenes from internal alkenes via olefin metathesis | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2013-10-29 | — | — | US | disclosed |
| US-8501973-B2 | Synthesis of terminal alkenes from internal alkenes via olefin metathesis | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2013-08-06 | — | — | US | disclosed |
| WO-2013095945-A1 | PROCESSES FOR PREPARING ESTOLIDE BASE OILS AND OLIGOMERIC COMPOUNDS THAT INCLUDE CROSS METATHESIS | BIOSYNTHETIC TECHNOLOGIES, LLC (US) | 2013-06-27 | — | — | WO | disclosed |
| US-20130158277-A1 | PROCESSES FOR PREPARING ESTOLIDE BASE OILS AND OLIGOMERIC COMPOUNDS THAT INCLUDE CROSS METATHESIS | BIOSYN HOLDINGS, LLC | 2013-06-20 | — | — | US | disclosed |
| US-20130035532-A1 | SYNTHESIS OF TERMINAL ALKENES FROM INTERNAL ALKENES VIA OLEFIN METATHESIS | Elevance Renewable Sciences. Inc (US) | 2013-02-07 | — | — | US | disclosed |
| US-20100145086-A1 | Synthesis of Terminal Alkenes From Internal Alkenes Via Olefin Metathesis | ELEVANCE RENEWABLE SCIENCES, INC. | 2010-06-10 | — | — | US | disclosed |
| EP-2076484-A2 | SYNTHESIS OF TERMINAL ALKENES FROM INTERNAL ALKENES VIA OLEFIN METATHESIS | Elevance Renewable Sciences, Inc. (US) | 2009-07-08 | — | — | EP | disclosed |
| WO-2008046106-A2 | SYNTHESIS OF TERMINAL ALKENES FROM INTERNAL ALKENES VIA OLEFIN METATHESIS | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2008-04-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140012023-A1 | PROCESSES FOR PREPARING ESTOLIDE BASE OILS AND OLIGOMERIC COMPOUNDS THAT INCLUDE CROSS METATHESIS | SQLE, ALOX12, ALOX15 | CYP3A4 1136/4885MAPT 2801/4885USP2 2898/4885 |
| US-20160102037-A1 | Methods of Making Functionalized Internal Olefins and Uses Thereof | ALDH7A1, STS, FDFT1 | CYP3A4 105/4885MAPT 4477/4885USP2 3177/4885 |
| US-20130158277-A1 | PROCESSES FOR PREPARING ESTOLIDE BASE OILS AND OLIGOMERIC COMPOUNDS THAT INCLUDE CROSS METATHESIS | SQLE, ALOX12, ALOX15 | CYP3A4 1136/4885MAPT 2801/4885USP2 2898/4885 |
| US-20160244397-A1 | PROCESSES FOR PREPARING ESTOLIDE BASE OILS AND BIOBASED COMPOUNDS THAT INCLUDE ETHYLENEOLYSIS | ELOVL1, FASN, ELOVL5 | CYP3A4 1222/4885MAPT 3947/4885USP2 1821/4885 |
| US-20130035532-A1 | SYNTHESIS OF TERMINAL ALKENES FROM INTERNAL ALKENES VIA OLEFIN METATHESIS | COASY, SQLE, POR | CYP3A4 89/4885MAPT 2992/4885USP2 740/4885 |
| US-20170057905-A1 | PROCESSES FOR PREPARING ESTOLIDE BASE OILS AND OLIGOMERIC COMPOUNDS THAT INCLUDE CROSS METATHESIS | SQLE, ALOX12, ALOX15 | CYP3A4 1136/4885MAPT 2801/4885USP2 2898/4885 |
| US-10011556-B2 | Processes for preparing estolide base oils and oligomeric compounds that include cross metathesis | SQLE, ALOX12, ALOX15 | CYP3A4 1136/4885MAPT 2801/4885USP2 2898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.